Fuji lands hospital as site for Synapse PACS productFuji Medical Systems USA has taken the next step in its quest to become a full-line PACS vendor with the signing of a beta-site agreement with the Hospital of Saint Raphael in New Haven, CT.
Fuji Medical Systems USA has taken the next step in its quest to become a full-line PACS vendor with the signing of a beta-site agreement with the Hospital of Saint Raphael in New Haven, CT. Saint Raphael will serve as the first installation for Fuji's Synapse PACS network, which the Stamford, CT, vendor rolled out last year (
PNN
12/97).
Fuji is developing Synapse as an enterprise-wide image and information management system, and Saint Raphael hopes the installation will help the hospital develop an electronic patient record. Saint Raphael already has experience as a Fuji computed radiography site, and the hospital's proximity to Fuji headquarters will facilitate the R&D process, Fuji said.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 2nd 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 2nd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 2nd 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.